BTX BTX

Brooklyn ImmunoTherapeut... Stock Price

0.8038
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
0.8038
Volume 0
Bid Price 0.7992
Ask Price 0.87
News -
Day High

Low
0.70

52 Week Range

High
10.00

Day Low
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Brooklyn ImmunoTherapeutics Inc BTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.8038 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.8038
Trades Volume Avg Volume 52 Week Range
0 0 - 0.70 - 10.00
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.8038 USD

Period:

Draw Mode:

Brooklyn ImmunoTherapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 46.18M 57.45M 51.55M $ - $ - -2.58 -0.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 2.05M 10.70%

more financials information »

Brooklyn ImmunoTherapeut... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.88520.94390.700.7790807797,940-0.0814-9.2%
1 Month1.461.46880.700.9846874538,817-0.6562-44.95%
3 Months2.202.380.701.56452,320-1.40-63.46%
6 Months7.717.950.703.15474,670-6.91-89.57%
1 Year9.8610.000.703.57481,324-9.06-91.85%
3 Years9.8610.000.703.57481,324-9.06-91.85%
5 Years9.8610.000.703.57481,324-9.06-91.85%

Brooklyn ImmunoTherapeut... Description

Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells.


Your Recent History
NASDAQ
BTX
Brooklyn I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.